Coverage
-
September 11, 2012
A New Jersey federal judge Tuesday declared valid the patent behind Johnson & Johnson's Ortho Tri-Cyclen Lo birth control drug, blocking a Lupin Pharmaceuticals Inc. effort to market a generic competitor.
2 other articles on this case.
View all »